C08 Calcium channel blockers Bloqueantes de los canales de calcio 钙通道阻滞剂 鈣通道阻滯劑 L2
Source: Editorial translation · editorial (project) Fuente: Traducción editorial · editorial (proyecto) 来源:编辑译名 · 编辑整理(项目) 來源:編輯譯名 · 編輯整理(專案)
ATC level L2 · Search this class · Consumer categories
Child classes
C08CSelective calcium channel blockers with mainly vascular effects Bloqueantes selectivos de canales de calcio con efectos principalmente vasculares 主要对血管产生影响的选择性钙通道阻断药 主要對血管產生影響的選擇性鈣通道阻斷藥C08DSelective calcium channel blockers with direct cardiac effects Bloqueantes selectivos de canales de calcio con efectos cardíacos directos 直接对心脏产生影响的选择性钙通道阻断药 直接對心臟產生影響的選擇性鈣通道阻斷藥C08ENon-selective calcium channel blockers Bloqueantes no selectivos de canales de calcio 非选择性钙通道阻断药 非選擇性鈣通道阻斷藥
Active ingredients in this class
28 active ingredients 28 principios activos 28 个活性成分 28 個有效成分
The market codes after a status are the markets where that status is recorded (same codes as the product tables). An ingredient can be on sale in one market and withdrawn in another; that is a record fact, not a safety judgement.
- 尼索地平
C08CAactiveCN - Nitrendipine
C08CAwithdrawnESactiveCN·ES·TWunknownMX - 尼群洛尔
C08CAactiveCN - Nimodipine
C08CAdiscontinuedCAactiveUS·GB·CA·AU·SG·CN·TWunknownAU·HK - Lacidipine
C08CA09withdrawnMXactiveGB·SG·CN·ES·TWunknownHK - 氯维地平
C08CAactiveCN - 盐酸乐卡地平
C08CAactiveCN - Diltiazem
C08DB01withdrawnES·MXdiscontinuedCA·ES·MXactiveUS·GB·CA·AU·SG·CN·ES·TWunknownAU·MX·HK - Nicardipine
C08CAdiscontinuedCAactiveUS·GB·CN·TWunknownHK - Barnidipine
C08CA12withdrawnESdiscontinuedESactiveCN·ESunknownMX - 盐酸洛美利嗪
C08EXactiveCN - Verapamil
C08DA01Salt form: Verapamil HydrochloridewithdrawnESdiscontinuedCA·MXactiveUS·GB·CA·AU·SG·CN·ES·MX·TWunknownAU·MX·HK - 盐酸苄普地尔
C08EAactiveCN - 盐酸贝尼地平
C08CAactiveCN - Manidipine
C08CA11withdrawnESactiveGB·CN·ES - Levamlodipine
C08CAactiveUS·SG·CN - Amlodipine
C08CA01Salt form: Amlodipine BesylatewithdrawnES·MX·EUdiscontinuedCA·ES·MXactiveUS·GB·CA·AU·SG·CN·ES·MX·TW·EUunknownAU·MX·HK·EU - Cilnidipine
C08CAactiveCN - 阿折地平
C08CAactiveCN - Felodipine
C08CA02withdrawnMXdiscontinuedCAactiveUS·GB·CA·AU·SG·CN·ES·MX·TWunknownAU·MX·HK - Clevidipine
C08CA16activeUS·GB·CA·ES·MXunknownAU - Etripamil
C08DA03activeUS - Isradipine
C08CA03activeUS·GB - Lercanidipine
C08CA13Salt form: Lercanidipine HydrochloridewithdrawnESdiscontinuedES·MXactiveGB·AU·ES·MX·TWunknownAU·MX·HK - Nicardipino
C08CA04withdrawnESactiveES - Nimodipino
C08CA06withdrawnES·MXdiscontinuedES·MXactiveES·MXunknownMX - Nisoldipine
C08CA07activeUS·GB - Perhexiline
C08EX02Salt form: Perhexiline MaleateactiveGB·AUunknownAU
Class names are editorial translations or come from Wikipedia (CC BY-SA 4.0) / Wikidata (CC0); each ATC page lists the exact source, licence and link for every language. Only the ATC code and the WHO hierarchy are authoritative.
Notes & licences
Status badges summarise the product records held for each ingredient (active / discontinued / withdrawn / unknown), and the market codes after each badge show where that status is recorded. Only some registers publish a status column: CA, ES and MX do; AU and HK have no status column and are recorded as unknown; CN, US, GB, TW and SG records are on the register and marked active.
Class and category names are editorial or AI-assisted translations; only the ATC code and the WHO hierarchy are authoritative.
ATC codes and hierarchy reference the WHO Collaborating Centre for Drug Statistics Methodology ATC/DDD Index (copyright WHOCC; the index itself is not reproduced). Ingredient/strength facts come from the regulator records listed on About.